Blood Podcast cover image

Long-term ibrutinib-rituximab vs FCR in CLL, procoagulant platelet sentinels in prevention of inflammatory bleeding, and new SERPINC1 variants in thrombophilia

Blood Podcast

00:00

Thrombophilia and Antithrombin

Jattergy believes that potential novel drug targets may emerge from the identification of subtle difference between phosphortital syrian exposing a poptotic versus pro coagulant platlets. In the final segment of to day's podcast, we will review a report published in blood entitled, two serpent one variants affecting englic oscillation of asperogene two 24 caused severe thrombo philia not detected by functional assays.

Play episode from 11:47
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app